Volume 4, Issue 2

• Dopamine D2 Receptors as Treatment argets in Schizophrenia
  Author(s): Philip Seeman
  • Abstract
• Clozapine for Treatment-Resistant Schizophrenia: National Institute of Clinical Excellence (NICE) Guidance in the Real World
  Author(s): Ann M. Mortimer , Praveen Singh , Charles J. Shepherd , Junais Puthiryackal
  • Abstract
  • PDF
• Methodological Challenges in Psychiatric Treatment Adherence Research
  Author(s): Dawn Velligan , Martha Sajatovic , Marcia Valenstein , William T. Riley , Steven Safren , Roberto Lewis-Fernandez , Peter Weiden , Gbenga Ogedegbe , Julian Jamison
  • Abstract
  • PDF
• Association of Stigma, Self-Esteem, and Symptoms with Concurrent and Prospective Assessment of Social Anxiety in Schizophrenia
  Author(s): Paul H. Lysaker , Philip T. Yanos , Jared Outcalt , David Roe
  • Abstract
  • PDF
• Suicidal Behavior in Adolescents with First-Episode Psychosis
  Author(s): Tatiana Falcone , Leenu Mishra , Erin Carlton , Catherine Lee , Robert S. Butler ,Damir Janigro , Barry Simon , Kathleen Franco
  • Abstract
  • PDF
• DSM-5 Posting and Commentaries
  Author(s): Peter F. Buckley
  • Abstract
  • PDF